Roche Holding AG (RHHVF)
244.00
+10.73
(+4.60%)
USD |
OTCM |
May 07, 15:55
Roche Price to Book Value: 5.574 for May 7, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
May 06, 2024 | 5.329 |
May 03, 2024 | 5.420 |
May 02, 2024 | 5.375 |
May 01, 2024 | 5.391 |
April 30, 2024 | 5.455 |
April 29, 2024 | 5.485 |
April 26, 2024 | 5.536 |
April 25, 2024 | 5.430 |
April 24, 2024 | 5.517 |
April 23, 2024 | 5.729 |
April 22, 2024 | 5.601 |
April 19, 2024 | 5.573 |
April 18, 2024 | 5.484 |
April 17, 2024 | 5.542 |
April 16, 2024 | 5.562 |
April 15, 2024 | 5.585 |
April 12, 2024 | 5.594 |
April 11, 2024 | 5.649 |
April 10, 2024 | 5.610 |
April 09, 2024 | 5.587 |
April 08, 2024 | 5.534 |
April 05, 2024 | 5.540 |
April 04, 2024 | 5.633 |
April 03, 2024 | 5.716 |
April 02, 2024 | 5.711 |
Date | Value |
---|---|
April 01, 2024 | 5.766 |
March 28, 2024 | 5.851 |
March 27, 2024 | 5.766 |
March 26, 2024 | 5.715 |
March 25, 2024 | 5.778 |
March 22, 2024 | 5.730 |
March 21, 2024 | 5.740 |
March 20, 2024 | 5.940 |
March 19, 2024 | 5.918 |
March 18, 2024 | 5.886 |
March 15, 2024 | 5.994 |
March 14, 2024 | 6.035 |
March 13, 2024 | 6.220 |
March 12, 2024 | 6.382 |
March 11, 2024 | 6.232 |
March 08, 2024 | 6.194 |
March 07, 2024 | 6.129 |
March 06, 2024 | 6.126 |
March 05, 2024 | 6.090 |
March 04, 2024 | 5.988 |
March 01, 2024 | 5.996 |
February 29, 2024 | 5.951 |
February 28, 2024 | 6.011 |
February 27, 2024 | 6.031 |
February 26, 2024 | 5.871 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
5.329
Minimum
May 06 2024
12.70
Maximum
Apr 11 2022
8.462
Average
8.341
Median
Price to Book Value Benchmarks
AC Immune SA | 1.231 |
CRISPR Therapeutics AG | 2.504 |
Addex Therapeutics Ltd | 7.171 |
NLS Pharmaceutics Ltd | -- |
Molecular Partners AG | 0.5553 |
Price to Book Value Related Metrics
PE Ratio | 15.24 |
PS Ratio | 2.897 |
Price to Free Cash Flow | 15.30 |
Price | 244.00 |
Earnings Yield | 6.56% |
Market Cap | 194.53B |
Operating PE Ratio | 11.39 |
Normalized PE Ratio | 15.07 |